Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward P Stern

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Rheumatic Diseases Clinics of North America|July 27, 2015
The Pathogenesis of Systemic SclerosisEdward P Stern, Christopher P Denton
Autoimmunity Reviews|February 19, 2017
Towards developing criteria for scleroderma renal crisis: A scoping reviewSabrina Hoa, Edward P Stern, Christopher P Denton, et al.
Rheumatology Advances in Practice|February 19, 2021
Exploring molecular pathology of chronic kidney disease in systemic sclerosis by analysis of urinary and serum proteinsEdward P Stern, Robert Unwin, Aine Burns, et al.
BMC Nephrology|August 17, 2014
Urine YKL-40 is associated with progressive acute kidney injury or death in hospitalized patientsIsaac E Hall, Edward P Stern, Lloyd G Cantley, et al.
Clinical and Experimental Rheumatology|October 18, 2016
UK Scleroderma Study Group (UKSSG) guidelines on the diagnosis and management of scleroderma renal crisisBernadette M Lynch, Edward P Stern, Voon Ong, et al.
Arthritis Research & Therapy|June 1, 2022
Zibotentan in systemic sclerosis-associated chronic kidney disease: a phase II randomised placebo-controlled trialEdward P Stern, Lauren V Host, Ivy Wanjiku, et al.
The Journal of Rheumatology|March 17, 2020
Analysis of Anti-RNA Polymerase III Antibody-positive Systemic Sclerosis and Altered GPATCH2L and CTNND2 Expression in Scleroderma Renal CrisisEdward P Stern, Sandra G Guerra, Harry Chinque, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Rheumatic Diseases Clinics of North America|July 27, 2015
The Pathogenesis of Systemic SclerosisEdward P Stern, Christopher P Denton
Autoimmunity Reviews|February 19, 2017
Towards developing criteria for scleroderma renal crisis: A scoping reviewSabrina Hoa, Edward P Stern, Christopher P Denton, et al.
Rheumatology Advances in Practice|February 19, 2021
Exploring molecular pathology of chronic kidney disease in systemic sclerosis by analysis of urinary and serum proteinsEdward P Stern, Robert Unwin, Aine Burns, et al.
BMC Nephrology|August 17, 2014
Urine YKL-40 is associated with progressive acute kidney injury or death in hospitalized patientsIsaac E Hall, Edward P Stern, Lloyd G Cantley, et al.
Clinical and Experimental Rheumatology|October 18, 2016
UK Scleroderma Study Group (UKSSG) guidelines on the diagnosis and management of scleroderma renal crisisBernadette M Lynch, Edward P Stern, Voon Ong, et al.
Arthritis Research & Therapy|June 1, 2022
Zibotentan in systemic sclerosis-associated chronic kidney disease: a phase II randomised placebo-controlled trialEdward P Stern, Lauren V Host, Ivy Wanjiku, et al.
The Journal of Rheumatology|March 17, 2020
Analysis of Anti-RNA Polymerase III Antibody-positive Systemic Sclerosis and Altered GPATCH2L and CTNND2 Expression in Scleroderma Renal CrisisEdward P Stern, Sandra G Guerra, Harry Chinque, et al.
Pageof 1